{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-063162","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2023-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.903442+00:00","generated_at":"2026-06-14T18:11:08.224958+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Ironwood to acquire VectivBio for $17.00/share; secures $500M credit facility","bullets":["Cash tender offer at $17.00/share for all VectivBio shares; minimum tender condition >80%.","Termination fees: VectivBio pays $23.68M if superior proposal; Ironwood pays $59.2M reverse fee.","$500M revolving credit facility from Wells Fargo; matures 2027; secured by substantially all assets.","Support agreement with shareholders owning ~28.6% of VectivBio shares agreeing to tender and vote.","VectivBio shareholders must remove voting cap and elect Ironwood designees to board."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-063162","json":"https://secwatch.observer/filing/0001104659-23-063162.json","markdown":"https://secwatch.observer/filing/0001104659-23-063162.md","text":"https://secwatch.observer/filing/0001104659-23-063162.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465923063162/0001104659-23-063162-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465923063162/tm2316415d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T18:11:08.224958+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f6169d6fea4234af2cda27f3144ff5df1d3829cf","claim":"IRONWOOD PHARMACEUTICALS INC incurred revolving credit.","evidence_excerpt":"The information included under Item 1.01 above under the heading \"Revolving Credit Agreement\" is incorporated herein by reference.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465923063162/0001104659-23-063162-index.htm","confidence":0.7,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"1ee9fd4f3e50aba8c1a92bc7193ee6980bf80323","claim":"IRONWOOD PHARMACEUTICALS INC entered into Transaction Agreement with VectivBio Holding AG (effective 2023-05-21).","evidence_excerpt":"On May 21, 2023, Ironwood Pharmaceuticals, Inc., a Delaware corporation (“Ironwood”), entered into a Transaction Agreement (the “Transaction Agreement”) with VectivBio Holding AG","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446847/000110465923063162/0001104659-23-063162-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"VectivBio Holding AG"},{"label":"Effective","value":"2023-05-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}